George D. Dangas, MD, PhD, MACC, MSCAI, is Professor of Medicine (Cardiology) & Surgery (Vascular) at Icahn School of Medicine & the Mount Sinai Hospital in New York, Associate Director of Mount Sinai Heart and Director, Cardiovascular Innovation at Mt Sinai Hospital, NYC and Chief of Cardiology Mount Sinai Queens; Director of Transcatheter Cardiovascular Therapeutics congress (TCT), Interventional Cardiology Principle & Practice Textbook Editor (Wiley Publishers, UK), and President of the Society for Cardiovascular Angiography & Interventions (SCAI) 2023-24. After studies at National Capodistrian University of Athens, served as Medical Officer, Hellenic Navy (including Hyperbaric/Diving Medicine) and then trained in Internal Medicine at Brown University/Miriam Hospital; subsequently he was Fellow in Cardiology and Interventional at Mount Sinai Hospital, New York, NY. Among the 5 founding physicians of Cardiovascular Research Foundation NYC, he was key faculty at Lenox Hill Hospital & Columbia University Medical Center and led establishment of Interventional Fellowship Programs in both. He is Board certified in all the disciples he practices. He served as Trustee of American College of Cardiology (ACC) & SCAI, Fellow of European Society of Cardiology (FESC) & the American Heart Association (FAHA), founding chair of ACC Interventional Council/Section, Cardiology Chair at Onassis Heart Center, Immediate Past-Chair of the AHA Laennec Society and AHA Invasive Cardiology Committee, and as JACC Journal Section Editor & Associate Editor among many other editorial board participations. He is designated a Master of ACC and Master of SCAI, ACC Distinguished Fellow 2019 & ACC Distinguished Teacher 2017 and included in many Top/Super Doctors & WHOisWHO lists for over 15 years.

Roxana Mehran, MD, is an internationally renowned interventional cardiologist, clinical research expert and trialist in the field of cardiovascular disease. She is amongst the most prolific researchers in the United States and is a globally-respected leader of an academic research center focused on designing and implementing randomized clinical trials, outcomes research projects, and high impact academic publications. She has served as principal investigator for numerous global studies, developed important practice guidelines for treating patients with cardiovascular disease. She has focused on personalized medicine and developed individual risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored over 1,800 peer-reviewed articles. Dr. Mehran currently serves as member and 2025-2026 Vice President on the Board of Trustees of The American College of Cardiology (ACC). She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF). She ranked 36th in the “Best Female Scientists in the World” and has been included for the past eight consecutive years in Clarivate Analytics: “Most Cited Researchers – Top 1%” as well as “The World’s Most Influential Scientific Minds”.

Dr. Megan Coylewright is a structural interventional cardiologist whose clinical practice includes minimally invasive options to treat congestive heart failure (through valve repair and replacement, including TAVR and TEER) and prevent stroke (LAAO and PFO closure). She is a frequent lecturer on technical and procedural topics as well as the intersection of health policy and patient-centred shared decision-making and is known for her advocacy to broaden access to cardiovascular therapies in clinical trials for women and patients of colour. Dr. Coylewright serves leadership roles for device trials of aortic stenosis, left atrial appendage closure, and interatrial shunt therapies, among others. She is the co- principal investigator for one of the largest studies of heart teams. She completed her medical school, residency, and Master of Public Health training at Johns Hopkins and served as health disparities coordinator at the Baltimore City Public Health Department. Five years of cardiovascular training were spent at the Mayo Clinic in her home state of Minnesota.

Dr Anthony Pisaniello is an interventional and structural cardiologist working on the Mornington Peninsula, and affiliated with the Victorian Heart Institute. He completed fellowships at The Johns Hopkins Hospital and Manchester Royal Infirmary after completing his PhD at The University of Adelaide. He is a SCAI International Committee member, and his research interests are focused on optimising TAVI outcomes.